Artificial intelligence-driven prostate cancer diagnosis: Enhancing accuracy and personalizing patient care.

Prostate cancer remains a major global burden; diagnostic pathways rely on prostate-specific antigen (PSA), multiparametric magnetic resonance imaging (mpMRI), and histopathology but face false positives, interobserver variability, and risk of overtr…

Preview only. Read the full abstract at the source